New Pharmacological Approaches for the Treatment of Neurotrophic Keratitis
Open Access
- 22 March 2022
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 13, 796854
Abstract
Neurotrophic keratitis (NK) is a rare degenerative condition that is caused by damage to the trigeminal nerve, with partial or complete loss of corneal sensory innervation. The loss of innervation leads to impaired healing of corneal epithelium, which subsequently results in punctate epithelial erosions, persistent epithelial defects, corneal ulcers and corneal perforation. Management of NK is often supportive and aims to promote epithelial healing and prevent progression of disease. Multiple novel pharmacological approaches have been proposed to address the underlying pathophysiology of NK, which are discussed in this paper.Keywords
This publication has 67 references indexed in Scilit:
- Episodes of Microbial Keratitis With Therapeutic Silicone Hydrogel Bandage Soft Contact LensesEye & Contact Lens: Science & Clinical Practice, 2013
- Topical 100% Serum Eye Drops for Treating Corneal Epithelial Defect after Ocular SurgeryBioMed Research International, 2013
- Effect of autologous platelet-rich plasma on persistent corneal epithelial defect after infectious keratitisJapanese Journal of Ophthalmology, 2012
- Improved Corneal Wound Healing through Modulation of Gap Junction Communication Using Connexin43-Specific Antisense OligodeoxynucleotidesInvestigative Ophthalmology & Visual Science, 2012
- Corneal nerve regeneration in neurotrophic keratopathy following autologous plasma therapyBritish Journal of Ophthalmology, 2009
- Serum eye drops, amniotic membrane and limbal epithelial stem cells—tools in the treatment of ocular surface diseaseCell and Tissue Banking, 2009
- Persistent Epithelial Defects Due to Neurotrophic Keratopathy Treated with a Substance P-Derived Peptide and Insulin-Like Growth Factor 1Japanese Journal of Ophthalmology, 2007
- Promotion of Corneal Epithelial Wound Healing by a Tetrapeptide (SSSR) Derived from IGF-1Investigative Ophthalmology & Visual Science, 2006
- Autologous serum application in the treatment of neurotrophic keratopathy*1Ophthalmology, 2004
- Topical treatment with nerve growth factor for neurotrophic keratitisOphthalmology, 2000